Treatment of COPD Exacerbation in Switzerland: Results and Recommendations of the European COPD Audit.

Buess, Michael; Schilter, Daniel; Schneider, Tino; Maurer, Marc; Borer, Heinz; Thurnheer, Robert; Köhler, Erich; Junker, Lilian; Jahn, Kathleen; Grob, Michael; Rüdiger, Jochen; Geiser, Thomas; Helfenstein, Erich; Solèr, Markus; Fiechter, René; Sigrist, Thomas; Brun, Patrick; Barandun, Jürg; Koltai, Eva; López-Campos, José Luis; ... (2017). Treatment of COPD Exacerbation in Switzerland: Results and Recommendations of the European COPD Audit. Respiration, 94(4), pp. 355-365. Karger 10.1159/000477911

[img]
Preview
Text
477911.pdf - Published Version
Available under License Publisher holds Copyright.

Download (170kB) | Preview

BACKGROUND The European COPD Audit initiated by the European Respiratory Society (ERS) evaluated the management of hospital admissions due to exacerbation of chronic obstructive pulmonary disease (COPD) in several European countries. Data on the treatment of severe acute exacerbations of COPD (AECOPDs) in Switzerland are scarce. OBJECTIVES In light of the GOLD 2010 guidelines, this work aims to examine the quality of care for AECOPD and to provide specific recommendations for the management of severe AECOPD in Switzerland. METHODS A total of 295 patients requiring hospital admission to 19 Swiss hospitals due to exacerbation of COPD during a predefined 60 days in 2011 were included in the study. We compared the Swiss data to the official GOLD 2010 recommendations and to the results of the other European countries. RESULTS Approximately 43% of the Swiss patients with severe AECOPD were current smokers at hospital admission, compared to 33% of the patients in other European countries (p < 0.001). In Switzerland and in Europe, spirometry data were not available for most patients at hospital admission (65 and 60%, respectively; p = 0.08). In comparison to other European countries, antibiotics were prescribed 14% less often in Switzerland (p < 0.001). Only 79% of the patients in the Swiss cohort received treatment with a short-acting bronchodilator at admission. CONCLUSIONS Considering the overall high standard of health care in Switzerland, in light of the GOLD 2010 guidelines we are able to make 7 recommendations to improve and standardize the management of severe AECOPD for patients treated in Switzerland.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Pneumology

UniBE Contributor:

Geiser, Thomas and Brun, Patrick

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0025-7931

Publisher:

Karger

Language:

English

Submitter:

Rahel Holderegger

Date Deposited:

27 Nov 2017 07:55

Last Modified:

24 Oct 2019 05:15

Publisher DOI:

10.1159/000477911

PubMed ID:

28719893

Uncontrolled Keywords:

Audit Bundle Chronic obstructive pulmonary disease ERS Europe Exacerbation GOLD Recommendations Switzerland Therapy

BORIS DOI:

10.7892/boris.106596

URI:

https://boris.unibe.ch/id/eprint/106596

Actions (login required)

Edit item Edit item
Provide Feedback